Long Term Treatment Strategies and Effectiveness of Secukinumab in Patient With JIA Subtypes of JPsA and ERA: Study From German BIKER Registry.

Clinical trial NCT07190053 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07190053
Sponsor: Novartis Pharmaceuticals
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Enthesitis-related Arthritis (ERA)Juvenile Psoriatic Arthritis (JPsA)

Start date: 2025-12-01
Primary completion: 2029-09-18
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.